JWH200
JWH200 is a synthetic cannabinoid that acts as a potent agonist for the cannabinoid receptors CB1 and CB2. It was first synthesized by John W. Huffman in the early 2000s as part of his research into cannabinoid receptor ligands. JWH200 is structurally similar to other synthetic cannabinoids that have been developed for recreational use, and it has been detected in illicit "spice" or "K2" products.
The pharmacological effects of JWH200 are primarily mediated by its binding to CB1 receptors, which are highly
Due to its potent activity and potential for harm, JWH200 is a controlled substance in many countries.